This company develops biological technology for efficient and scalable recombinant protein production. Their platform enables clients to produce high-quality, cost-effective recombinant proteins locally, streamlining the manufacturing process for various applications.
Funding
Funding not disclosed
Founders
Product
Problem
Developing countries face significant challenges in accessing high-quality, cost-effective recombinant proteins and enzymes, hindering advancements in vaccine development, diagnostics, and biopharmaceutical research. Traditional protein production methods often involve complex equipment, harsh chemicals, and long lead times, making local manufacturing difficult and expensive.
Solution
Fluorobiotech addresses these challenges by providing efficient and scalable recombinant protein and enzyme production solutions tailored for regional bioeconomies. Their patented SelfPrep technology simplifies enzyme manufacturing, boosting extraction efficiency and protein yield while minimizing dependence on complex equipment and harsh chemicals. This streamlined approach enables local, cost-effective production of high-value enzymes, supporting vaccine developers, researchers, and biopharma innovators. Fluorobiotech offers molecular enzymes for in vitro transcription (IVT) workflows, local enzyme supply services, and technology licensing for large-scale manufacturers.
Target Audience
Fluorobiotech serves vaccine developers, researchers, and biopharma innovators, particularly in developing countries, seeking affordable and reliable access to high-quality enzymes and recombinant proteins.
Features
- Patented SelfPrep technology for efficient and scalable enzyme production
- Increased extraction rates leading to higher protein yields
- Reduced production costs through streamlined manufacturing processes
- Resource-efficient processes minimizing dependence on complex equipment and harsh chemicals
- Reduced lead times enabling regional manufacturing and improved supply reliability
- Molecular enzymes for in vitro transcription (IVT) workflows, mRNA vaccine manufacturing, diagnostics, and research
- Tailored enzyme production solutions for more affordable and consistent supply
- Technology licensing for large-scale manufacturers seeking cost and process efficiencies